Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Atomic AI Inc. is currently prosecuting a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The company has 1 pending office action, which represents the total active workload for its USPTO filings. This action is being reviewed within 1 distinct art unit, reflecting a specific focus for the company's current biotechnology claims. For practitioners, this concentrated activity suggests that the company is prioritizing a specific technical advancement in the life sciences sector.
The prosecution is overseen by 1 distinct examiner, PULLIAM, JOSEPH CONSTANTINE, who is the busiest examiner with 1 pending office action. As the only examiner currently reviewing the company's applications, the prosecution strategy is entirely focused on this single individual. This concentrated activity in the Biotechnology & Pharmaceuticals sector allows for a dedicated approach to the lone pending matter. The 1 distinct art unit involved indicates that the company's current legal efforts are not fragmented across different technical divisions. This streamlined structure facilitates a more direct engagement with the USPTO during the examination of the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PULLIAM, JOSEPH CONSTANTINE | 1 | 38.5% | +33.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18452480 | METHODS, SYSTEMS, AND MEDIA METHOD APPLYING MACHINE LEARNING TO CHEMICAL MAPPING DATA FOR RNA TERTIARY STRUCTURE PREDICTION | PULLIAM, JOSEPH CONSTANTINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18452480 | METHODS, SYSTEMS, AND MEDIA METHOD APPLYING MACHINE LEARNING TO CHEMICAL MAPPING DATA FOR RNA TERTIARY STRUCTURE PREDICTION | PULLIAM, JOSEPH CONSTANTINE | — |
| Art Unit | Apps |
|---|---|
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18452480 | METHODS, SYSTEMS, AND MEDIA METHOD APPLYING MACHINE LEARNING TO CHEMICAL MAPPING DATA FOR RNA TERTIARY STRUCTURE PREDICTION | PULLIAM, JOSEPH CONSTANTINE | 1687 | §101§103§112 | Non-Final OA | — | Pending | Aug 18, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAtomic AI Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Joseph Constantine Pulliam has the most, with 1 of Atomic AI Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
